Clinical Trial Update: Efficacy of Changing to TRAVATAN® From Prior Therapy [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy of switching to TRAVATAN from prior therapy in open-angle glaucoma and ocular hypertension; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Travatan (travoprost)

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2014-05-09